Projected worldwide disease burden from giant cell arteritis by 2050

E De Smit, AJ Palmer, AW Hewitt - The Journal of rheumatology, 2015 - jrheum.org
Objective. To estimate and project the number of people affected worldwide by giant cell
arteritis (GCA) by 2050. Modeling the number of people visually impaired as a result of this …

Giant cell arteritis: ophthalmic manifestations of a systemic disease

E De Smit, E O'Sullivan, DA Mackey… - Graefe's Archive for …, 2016 - Springer
Background Giant cell arteritis (GCA) is a systemic granulomatous vasculitis, primarily
affecting medium-large arteries. It has a predilection for the aorta and its major branches, …

[HTML][HTML] Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy

…, S Jackson, S Khan, NJ Van Bergen, E De Smit… - Aging (Albany …, 2017 - ncbi.nlm.nih.gov
Cybrid technology was used to replace Leber hereditary optic neuropathy (LHON) causing
mitochondrial DNA (mtDNA) mutations from patient-specific fibroblasts with wildtype mtDNA, …

Development of a modular automated system for maintenance and differentiation of adherent human pluripotent stem cells

…, SS Hung, KP Gill, E De Smit… - … Life Sciences R&D, 2017 - journals.sagepub.com
Patient-specific induced pluripotent stem cells (iPSCs) have tremendous potential for
development of regenerative medicine, disease modeling, and drug discovery. However, the …

Geo-epidemiology of temporal artery biopsy-positive giant cell arteritis in Australia and New Zealand: is there a seasonal influence?

E De Smit, L Clarke, PG Sanfilippo, TR Merriman… - RMD open, 2017 - rmdopen.bmj.com
Objective Previous studies, although inconclusive, have suggested possible associations of
environmental risk factors with the development of giant cell arteritis (GCA). We aim to …

Participant understanding and recall of informed consent for induced pluripotent stem cell biobanking

T McCaughey, CY Chen, E De Smit, G Rees… - Cell and tissue …, 2016 - Springer
The ability to generate human induced pluripotent stem cells (iPSCs) has opened new
avenues for human disease modelling and therapy. The aim of our study was to determine …

[HTML][HTML] Longitudinal expression profiling of CD4+ and CD8+ cells in patients with active to quiescent giant cell arteritis

E De Smit, SW Lukowski, L Anderson… - BMC Medical …, 2018 - Springer
Background Giant cell arteritis (GCA) is the most common form of vasculitis affecting elderly
people. It is one of the few true ophthalmic emergencies but symptoms and signs are …

[HTML][HTML] Heterogeneity of human research ethics committees and research governance offices across Australia: an observational study

E De Smit, LS Kearns, L Clarke, J Dick… - The Australasian …, 2016 - ncbi.nlm.nih.gov
Background Conducting ethically grounded research is a fundamental facet of all investigations.
Nevertheless, the administrative burdens of current ethics review are substantial, and …

PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis

…, AW Hewitt, CD Ruediger, L Bradbury, E De Smit… - RMD open, 2016 - rmdopen.bmj.com
Giant cell arteritis (GCA) is one of the commonest forms of vasculitis in the elderly, and may
result in blindness and stroke. The pathogenesis of GCA is not understood, although …

Cotton-wool spots in giant cell arteritis

E De Smit, E O'Sullivan - CMAJ, 2013 - Can Med Assoc
A71-year-old woman presented with re-duced vision in her right eye. She also reported
having a headache, scalp tenderness and pain in her jaw when chewing. On funduscopy, …